Simoer Earns Eurofins CTF Lab Accreditation Qualification

Aug.15.2022
Simoer Earns Eurofins CTF Lab Accreditation Qualification
Simoer's analysis and testing center received CTF laboratory accreditation from Eurofins, a leading scientific analysis and certification agency.

On August 15th at 8:00 PM, Smore technology announced through its official public account, "Smore Technology", that their Smore Analysis and Testing Center for Security Assessment has received accreditation from Eurofins, a global leader in scientific analysis and testing certification, for their CTF laboratory.


Eurofins is an internationally recognized testing and certification institution with over 900 laboratories in 54 countries worldwide. They specialize in various fields including power batteries, medical devices, explosion-proof products, and industrial machinery, utilizing over 200,000 reliable analysis methods. With an impressive 450 million tests conducted annually, Eurofins is highly regarded in their industry.


The image is sourced from SIMO Technology's official public account.


According to reports, Eurofins has assessed and audited the CTF accredited laboratory for its SEMI analysis testing and safety evaluations in accordance with IECEE's requirements. The laboratory has been issued a certification of accreditation by Eurofins.


CTF, also known as Customer Testing Facilities, refers to a laboratory for testing electrical products. Smoltech has recently completed the IECEE-CB (the mutual recognition system for testing electrical products) Scheme CTF certification. After receiving this certification, Smoltech's safety tests can be mutually recognized by the 54 IECEE member countries globally. Following the unveiling of the CTF laboratory certification, customers from all over the world can access Smoltech's CTF laboratory on the IEC website. They can directly indicate the name and address of the laboratory in globally recognized CB reports.


Furthermore, Summor Analysis Testing and Safety Assessment Center also undertakes market access testing for electronic vaporizer products including the US PMTA and EU TPD.


This article contains excerpts or reprints from third-party sources. The copyright belongs to the original media and author. If there is any infringement, please contact us for removal. Any individual or organization wishing to reprint should contact the author and not republish directly.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Japan Tobacco Launches Limited Edition "Aqua Halo" of Ploom X Advanced in Korea from May
Japan Tobacco Launches Limited Edition "Aqua Halo" of Ploom X Advanced in Korea from May
Japan Tobacco International Korea announced that it will launch the first limited edition device "Aqua Halo" of its HTP device "Ploom X Advanced" in South Korea on May 1, priced at approximately $54.
Apr.29 by 2FIRSTS.ai
Russian State Duma Health Committee Calls for Full Ban on Domestic E-Cigarette Production and Sales
Russian State Duma Health Committee Calls for Full Ban on Domestic E-Cigarette Production and Sales
Sergei Leonov, Chair of the Russian State Duma Health Committee, has publicly called for a nationwide ban on the production and sale of e-cigarettes. Although sales to minors are already prohibited, underage use remains a concern.
May.26 by 2FIRSTS.ai
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
Russian NGO Calls for Halt of 2025 E-cigarette Expo, Citing Illegal Promotion of Nicotine Products
Russian NGO Calls for Halt of 2025 E-cigarette Expo, Citing Illegal Promotion of Nicotine Products
The Russian social movement organization "Сорок Сороков" has filed complaints with the prosecutors' offices in Moscow and Novosibirsk, demanding the ban of the 2025 E-cigarette Expo (Vape Club Show). The complainants argue that the event constitutes illegal promotion of nicotine products and sets a bad example for young people.
May.07 by 2FIRSTS.ai
Mylor Bio Launches NaSweet-C and NaSweet-X Sweeteners for Vaping Devices
Mylor Bio Launches NaSweet-C and NaSweet-X Sweeteners for Vaping Devices
At Vaper Expo May 2025, Mylor Bio Co., Ltd. is showcasing the NaSweet series of professional atomized sweetener solutions, which consists of two innovative products, NaSweet-C, designed for ceramic coil devices, and NaSweet-X, which is compatible with cotton coil devices.
May.12
WHO: Global Smoking Rate Down By One-Third Since Tobacco Control Treaty Took Effect 20 Years Ago
WHO: Global Smoking Rate Down By One-Third Since Tobacco Control Treaty Took Effect 20 Years Ago
WHO chief Tedros said at the 78th World Health Assembly that global smoking rates have fallen by one-third since the tobacco control treaty took effect 20 years ago, preventing up to 300 million new smokers. He called for stronger regulation of e-cigarettes and new tobacco products.
May.20 by 2FIRSTS.ai